Company
Staar Surgical
19.35 0.20 (1.04%)
--%

Staar Surgical

$ 19.35 0.20 (1.04%)

NASDAQ:STAA - Updated Apr. 22nd 4:00pm

STAAR Surgical was incorporated in the state of California in 1982. It was reincorporated in Delaware in 1986. The Company designs, develops, manufactures and sells implantable lenses for the eye. The Company is a maker of lenses used in corrective surgery, and it also makes lenses for use in surgery that treats cataracts. All of the lenses it make are foldable, which permits the surgeon to insert them through a small incision during minimally invasive surgery. The Company maintains manufacturing and administrative facilities in the United States, Switzerland and Japan. The Company operates its administrative headquarters and a manufacturing facility in Monrovia, California. The Monrovia manufacturing facility principally makes Collamer and silicone IOLs and injector systems for IOLs and ICLs. The Company also currently manufactures the raw material for Collamer lenses (both IOLs and ICLs) and the AquaFlow Device (for the treatment of glaucoma) in a facility in Aliso Viejo, California. It operates an administrative, manufacturing and distribution facility in Nidau, Switzerland under its wholly owned subsidiary, STAAR Surgical AG. The Nidau manufacturing facility makes all of STAAR's Visian ICL products and also manufactures the AquaFlow Device. It operates administrative, manufacturing and distribution facilities in Japan under its wholly owned subsidiary, STAAR Japan Inc. STAAR Japan's administrative facility is located in Shin-Urayasu and its manufacturing and distribution facility is located in Ichikawa City. STAAR currently assembles all of its preloaded IOL injectors at the Ichikawa City facility. The Company competes with Novartis, Abbott and Valeant. The Company is subject to periodic inspection by the FDA for compliance with the FDA's quality system regulations and requirements, such as restrictions on advertising and promotion.

Read More

727.1M
Market
Cap
38.0M
Total
Shares
344.83
P.E.
Ratio
180.2K
Avg.
Volume

Welcome to Staar Surgical’s profile. Nobody has interacted yet, be the first to comment, share, or favorite Staar Surgical.

Financials

Competitors

26

Executives

Stock Price

798

SEC Documents

Money Memory

Comments

Fans

Executive Compensation

Board and Committee

Latest News

Insider Activity

Did You Know?

FAQs

Office Location

About

News Pulse

Tweet This

Social Activity

Last updated: 04/23/2014, 8:36 AM EDT
PassFail
Financials